195 related articles for article (PubMed ID: 12036448)
1. High expression of human uroplakin Ia in urinary bladder transitional cell carcinoma.
Kageyama S; Yoshiki T; Isono T; Tanaka T; Kim CJ; Yuasa T; Okada Y
Jpn J Cancer Res; 2002 May; 93(5):523-31. PubMed ID: 12036448
[TBL] [Abstract][Full Text] [Related]
2. Expression of transitional cell-specific genes, uroplakin Ia and II, in bladder cancer: detection of circulating cancer cells in the peripheral blood of metastatic patients.
Yuasa T; Yoshiki T; Isono T; Tanaka T; Hayashida H; Okada Y
Int J Urol; 1999 Jun; 6(6):286-92. PubMed ID: 10404304
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning and expression of uroplakins in transitional cell carcinoma.
Yuasa T; Yoshiki T; Isono T; Tanaka T; Okada Y
Adv Exp Med Biol; 2003; 539(Pt A):33-46. PubMed ID: 15088894
[TBL] [Abstract][Full Text] [Related]
4. Uroplakin as a marker for typing metastatic transitional cell carcinoma on fine-needle aspiration specimens.
Xu X; Sun TT; Gupta PK; Zhang P; Nasuti JF
Cancer; 2001 Jun; 93(3):216-21. PubMed ID: 11391610
[TBL] [Abstract][Full Text] [Related]
5. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder.
Elsamman E; Fukumori T; Kasai T; Nakatsuji H; Nishitani MA; Toida K; Ali N; Kanayama HO
BJU Int; 2006 Jun; 97(6):1202-7. PubMed ID: 16686711
[TBL] [Abstract][Full Text] [Related]
6. Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer.
Matsumoto K; Satoh T; Irie A; Ishii J; Kuwao S; Iwamura M; Baba S
Urology; 2008 Aug; 72(2):444-9. PubMed ID: 18313120
[TBL] [Abstract][Full Text] [Related]
7. Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas.
Moll R; Wu XR; Lin JH; Sun TT
Am J Pathol; 1995 Nov; 147(5):1383-97. PubMed ID: 7485401
[TBL] [Abstract][Full Text] [Related]
8. Differential immunocytochemical staining patterns of uroplakin observed on neoplastic and nonneoplastic tissue fragments obtained from upper urinary tract brush specimens.
Xu X; Genega EM; Nasuti JF
Acta Cytol; 2002; 46(4):684-9. PubMed ID: 12146031
[TBL] [Abstract][Full Text] [Related]
9. Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder.
Li SM; Zhang ZT; Chan S; McLenan O; Dixon C; Taneja S; Lepor H; Sun TT; Wu XR
J Urol; 1999 Sep; 162(3 Pt 1):931-5. PubMed ID: 10458411
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression in urinary bladder transitional cell carcinoma and its association with clinicopathological characteristics.
Tabriz HM; Olfati G; Ahmadi SA; Yusefnia S
Asian Pac J Cancer Prev; 2013; 14(8):4539-43. PubMed ID: 24083698
[TBL] [Abstract][Full Text] [Related]
11. Comparison of uroplakin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats and mice.
Ogawa K; St John M; Luiza de Oliveira M; Arnold L; Shirai T; Sun TT; Cohen SM
Toxicol Pathol; 1999; 27(6):645-51. PubMed ID: 10588545
[TBL] [Abstract][Full Text] [Related]
12. Expression of uroplakin Ib and uroplakin III genes in tissues and peripheral blood of patients with transitional cell carcinoma.
Yuasa T; Yoshiki T; Tanaka T; Kim CJ; Isono T; Okada Y
Jpn J Cancer Res; 1998 Sep; 89(9):879-82. PubMed ID: 9818021
[TBL] [Abstract][Full Text] [Related]
13. Uroplakin gene expression in normal human tissues and locally advanced bladder cancer.
Olsburgh J; Harnden P; Weeks R; Smith B; Joyce A; Hall G; Poulsom R; Selby P; Southgate J
J Pathol; 2003 Jan; 199(1):41-9. PubMed ID: 12474225
[TBL] [Abstract][Full Text] [Related]
14. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
May M; Nitzke T; Helke C; Vogler H; Hoschke B
Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
Messing EM
Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
[TBL] [Abstract][Full Text] [Related]
16. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
[TBL] [Abstract][Full Text] [Related]
17. Epithelial differentiation antigens and epidermal growth factor receptors in transitional cell bladder carcinoma: correlation with prognosis.
Nakopoulou L; Zervas A; Constantinides C; Deliveliotis C; Stefanaki K; Dimopoulos C
Urol Int; 1995; 54(4):191-7. PubMed ID: 7541921
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
Suzuki K; Morita T; Tokue A
Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
[TBL] [Abstract][Full Text] [Related]
19. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
Zhou JT; Cai ZM; Li NC; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
[TBL] [Abstract][Full Text] [Related]
20. Expression of prostate-specific membrane antigen in transitional cell carcinoma of the bladder: prognostic value?
Gala JL; Loric S; Guiot Y; Denmeade SR; Gady A; Brasseur F; Heusterspreute M; Eschwège P; De Nayer P; Van Cangh P; Tombal B
Clin Cancer Res; 2000 Oct; 6(10):4049-54. PubMed ID: 11051255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]